ASX - By Stock
|
NEU |
Re:
Daybue Rollout
|
|
aurel19672003
|
128 |
63K |
44 |
02/01/24 |
02/01/24 |
ASX - By Stock
|
128
|
63K
|
44
|
|
ASX - By Stock
|
WBC |
Re:
WBC WESTPAC BANKING CORPORATION
|
|
aurel19672003
|
87 |
42K |
0 |
05/12/23 |
05/12/23 |
ASX - By Stock
|
87
|
42K
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Daybue Feedback
|
|
aurel19672003
|
47 |
22K |
11 |
06/11/23 |
06/11/23 |
ASX - By Stock
|
47
|
22K
|
11
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
aurel19672003
|
9.9K |
4.4M |
29 |
16/08/23 |
16/08/23 |
ASX - By Stock
|
9.9K
|
4.4M
|
29
|
|
ASX - By Stock
|
NEU |
Re:
Satisfied Shareholders
|
|
aurel19672003
|
28 |
13K |
1 |
26/04/23 |
26/04/23 |
ASX - By Stock
|
28
|
13K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Satisfied Shareholders
|
|
aurel19672003
|
28 |
13K |
14 |
25/04/23 |
25/04/23 |
ASX - By Stock
|
28
|
13K
|
14
|
|
ASX - By Stock
|
NEU |
Merck to acquire Prometheus in a US$ 10.8 b deal
|
|
aurel19672003
|
107 |
62K |
47 |
18/04/23 |
18/04/23 |
ASX - By Stock
|
107
|
62K
|
47
|
|
ASX - By Stock
|
NEU |
Re:
Share Price Target IF approved.
|
|
aurel19672003
|
67 |
34K |
1 |
02/03/23 |
02/03/23 |
ASX - By Stock
|
67
|
34K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Share Price Target IF approved.
|
|
aurel19672003
|
67 |
34K |
11 |
02/03/23 |
02/03/23 |
ASX - By Stock
|
67
|
34K
|
11
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Rett Syndrome NDA accepted for Priority Review by FDA
|
|
aurel19672003
|
163 |
80K |
11 |
22/09/22 |
22/09/22 |
ASX - By Stock
|
163
|
80K
|
11
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Rett Syndrome NDA accepted for Priority Review by FDA
|
|
aurel19672003
|
163 |
80K |
11 |
22/09/22 |
22/09/22 |
ASX - By Stock
|
163
|
80K
|
11
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Pharmaceuticals with Proactive at ASX Small and Mid-Cap Conference
|
|
aurel19672003
|
78 |
39K |
25 |
22/09/22 |
22/09/22 |
ASX - By Stock
|
78
|
39K
|
25
|
|
Charts
|
NEU |
Re:
NEU chart
|
|
aurel19672003
|
1.6K |
829K |
4 |
04/08/22 |
04/08/22 |
Charts
|
1.6K
|
829K
|
4
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
aurel19672003
|
9.9K |
4.4M |
13 |
24/05/22 |
24/05/22 |
ASX - By Stock
|
9.9K
|
4.4M
|
13
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
aurel19672003
|
9.9K |
4.4M |
25 |
20/05/22 |
20/05/22 |
ASX - By Stock
|
9.9K
|
4.4M
|
25
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
aurel19672003
|
9.9K |
4.4M |
8 |
14/04/22 |
14/04/22 |
ASX - By Stock
|
9.9K
|
4.4M
|
8
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
aurel19672003
|
9.9K |
4.4M |
32 |
14/04/22 |
14/04/22 |
ASX - By Stock
|
9.9K
|
4.4M
|
32
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Q4 2021 quarterly activity and cash flow report
|
|
aurel19672003
|
42 |
17K |
6 |
21/02/22 |
21/02/22 |
ASX - By Stock
|
42
|
17K
|
6
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Q4 2021 quarterly activity and cash flow report
|
|
aurel19672003
|
42 |
17K |
7 |
21/02/22 |
21/02/22 |
ASX - By Stock
|
42
|
17K
|
7
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Q4 2021 quarterly activity and cash flow report
|
|
aurel19672003
|
42 |
17K |
8 |
31/01/22 |
31/01/22 |
ASX - By Stock
|
42
|
17K
|
8
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
aurel19672003
|
9.9K |
4.4M |
20 |
17/01/22 |
17/01/22 |
ASX - By Stock
|
9.9K
|
4.4M
|
20
|
|
ASX - By Stock
|
NEU |
Re:
TROFINETIDE TRIALS UPDATE
|
|
aurel19672003
|
218 |
130K |
19 |
13/01/22 |
13/01/22 |
ASX - By Stock
|
218
|
130K
|
19
|
|
ASX - By Stock
|
NEU |
Re:
TROFINETIDE TRIALS UPDATE
|
|
aurel19672003
|
218 |
130K |
22 |
13/01/22 |
13/01/22 |
ASX - By Stock
|
218
|
130K
|
22
|
|
ASX - By Stock
|
NEU |
Re:
ACAD presentation
|
|
aurel19672003
|
36 |
21K |
46 |
12/01/22 |
12/01/22 |
ASX - By Stock
|
36
|
21K
|
46
|
|
ASX - By Stock
|
NEU |
Re:
Evans partners report on Neu
|
|
aurel19672003
|
37 |
21K |
9 |
17/11/21 |
17/11/21 |
ASX - By Stock
|
37
|
21K
|
9
|
|
ASX - By Stock
|
NST |
Re:
Valuing gold producers
|
|
aurel19672003
|
39 |
23K |
18 |
05/11/21 |
05/11/21 |
ASX - By Stock
|
39
|
23K
|
18
|
|
ASX - By Stock
|
FMG |
Re:
FMG Profitability when IO at $50-60USD?
|
|
aurel19672003
|
77 |
41K |
1 |
23/10/21 |
23/10/21 |
ASX - By Stock
|
77
|
41K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Ann: FDA grants Orphan Drug designation for Prader-Willi syndrome
|
|
aurel19672003
|
22 |
14K |
14 |
21/09/21 |
21/09/21 |
ASX - By Stock
|
22
|
14K
|
14
|
|
ASX - By Stock
|
NEU |
Re:
TROFINETIDE TRIALS UPDATE
|
|
aurel19672003
|
218 |
130K |
12 |
18/08/21 |
18/08/21 |
ASX - By Stock
|
218
|
130K
|
12
|
|
ASX - By Stock
|
NEU |
Re:
Updated MST report - target of $3.68 a share
|
|
aurel19672003
|
219 |
110K |
15 |
12/08/21 |
12/08/21 |
ASX - By Stock
|
219
|
110K
|
15
|
|
ASX - By Stock
|
NEU |
Re:
Updated MST report - target of $3.68 a share
|
|
aurel19672003
|
219 |
110K |
29 |
12/08/21 |
12/08/21 |
ASX - By Stock
|
219
|
110K
|
29
|
|
ASX - By Stock
|
MSB |
Re:
Ann: EAP for Remestemcel-L in Children with MIS-C due to COVID-19
|
|
aurel19672003
|
425 |
188K |
2 |
26/08/20 |
26/08/20 |
ASX - By Stock
|
425
|
188K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Chances of Covid Trial being a success
|
|
aurel19672003
|
101 |
56K |
4 |
24/08/20 |
24/08/20 |
ASX - By Stock
|
101
|
56K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Chances of Covid Trial being a success
|
|
aurel19672003
|
101 |
56K |
7 |
24/08/20 |
24/08/20 |
ASX - By Stock
|
101
|
56K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Video Thread
|
|
aurel19672003
|
72 |
33K |
9 |
20/08/20 |
20/08/20 |
ASX - By Stock
|
72
|
33K
|
9
|
|
ASX - By Stock
|
NEU |
Re:
Acadia Update 5th August
|
|
aurel19672003
|
8 |
5.1K |
8 |
08/08/20 |
08/08/20 |
ASX - By Stock
|
8
|
5.1K
|
8
|
|
ASX - By Stock
|
NEU |
Re:
Acadia Update 5th August
|
|
aurel19672003
|
8 |
5.1K |
12 |
08/08/20 |
08/08/20 |
ASX - By Stock
|
8
|
5.1K
|
12
|
|
ASX - By Stock
|
NEU |
Re:
Trading
|
|
aurel19672003
|
467 |
2.3M |
25 |
26/07/20 |
26/07/20 |
ASX - By Stock
|
467
|
2.3M
|
25
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Proposed issue of Securities - NEU
|
|
aurel19672003
|
33 |
14K |
2 |
07/07/20 |
07/07/20 |
ASX - By Stock
|
33
|
14K
|
2
|
|
ASX - By Stock
|
NEU |
Re:
NEU Shorting Continues
|
|
aurel19672003
|
8 |
4.3K |
2 |
02/07/20 |
02/07/20 |
ASX - By Stock
|
8
|
4.3K
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Ann: AGM Chairman's Address and CEO Presentation
|
|
aurel19672003
|
16 |
8.9K |
1 |
01/07/20 |
01/07/20 |
ASX - By Stock
|
16
|
8.9K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Ann: AGM Chairman's Address and CEO Presentation
|
|
aurel19672003
|
16 |
8.9K |
5 |
30/06/20 |
30/06/20 |
ASX - By Stock
|
16
|
8.9K
|
5
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Trading Halt
|
|
aurel19672003
|
113 |
43K |
1 |
25/06/20 |
25/06/20 |
ASX - By Stock
|
113
|
43K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
FB Live Chat: Current State of Rett Syndrome Research
|
|
aurel19672003
|
7 |
4.1K |
12 |
10/06/20 |
10/06/20 |
ASX - By Stock
|
7
|
4.1K
|
12
|
|
ASX - By Stock
|
NEU |
FB Live Chat: Current State of Rett Syndrome Research
|
|
aurel19672003
|
7 |
4.1K |
17 |
03/06/20 |
03/06/20 |
ASX - By Stock
|
7
|
4.1K
|
17
|
|
ASX - By Stock
|
NEU |
Re:
MST Valuation
|
|
aurel19672003
|
15 |
8.3K |
0 |
29/05/20 |
29/05/20 |
ASX - By Stock
|
15
|
8.3K
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Neuren announces changes to leadership team
|
|
aurel19672003
|
55 |
20K |
8 |
27/05/20 |
27/05/20 |
ASX - By Stock
|
55
|
20K
|
8
|
|
ASX - By Stock
|
NEU |
Re:
ACADIA TALKS TROFINETIDE
|
|
aurel19672003
|
84 |
35K |
5 |
14/05/20 |
14/05/20 |
ASX - By Stock
|
84
|
35K
|
5
|
|
ASX - By Stock
|
NEU |
Re:
ACADIA TALKS TROFINETIDE
|
|
aurel19672003
|
84 |
35K |
13 |
14/05/20 |
14/05/20 |
ASX - By Stock
|
84
|
35K
|
13
|
|
ASX - By Stock
|
NEU |
Re:
ACADIA TALKS TROFINETIDE
|
|
aurel19672003
|
84 |
35K |
17 |
09/05/20 |
09/05/20 |
ASX - By Stock
|
84
|
35K
|
17
|
|